ReviewBiodegradation2026
Genetically engineered organisms for sustainable bioremediation of polluted environments.
Review in Biodegradation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Environmental pollution, a critical global challenge fuelled by industrialization, urbanization, and population growth, threatens ecosystems, biodiversity, and public health. Genetically engineered organisms (GEOs)-bacteria, fungi, algae, and plants provide innovative bioremediation strategies to combat this crisis by degrading or detoxifying pollutants, including hydrocarbons, heavy metals, pesticides, and microplastics. Through targeted genetic modifications, such as enzyme or metabolic pathway enhancements, GEOs improve pollutant degradation efficiency, environmental adaptability, and resilience in contaminated ecosystems. This review synthesizes GEO-based bioremediation mechanisms, including bioaugmentation, bio-stimulation, and phytoremediation, and their applications across water, soil, and air pollution. We highlight GEOs' specificity, sustainability, and long-term efficacy while addressing ecological risks, such as unintended gene transfer, regulatory complexities, and ethical concerns. Case studies demonstrate synergies with emerging technologies like nanotechnology and biosensors, optimizing bioremediation outcomes. Despite challenges, advancements in multi-functional GEOs and regulatory frameworks, coupled with innovations like Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), promise to bridge gaps and enhance scalability. Future research should prioritise ecological safety and regulatory alignment to fully harness GEOs' potential, ensuring sustainable, eco-friendly solutions for managing complex modern pollution.
Indexed as
Identifiers
41817641What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.